Latest Ratings for LXRX Date Firm Action From To Jan 2021 Wedbush Downgrades Outperform Neutral Jan 2021 JP Morgan Upgrades Underweight Neutral Dec 2020 Citigroup Upgrades Neutral Buy View More Analyst Ratings for LXRX View the Lates...
Beyond The Numbers: 7 Analysts Discuss Lexicon Pharmaceuticals Stock